 Home > Medical News > Latest Medical News > Luoxin Pharmaceutical and HK inno.N of South Korea join hands again, aiming at the US$2 billion Chinese PPI injection market

Luoxin Pharmaceutical and HK inno.N of South Korea join hands again, aiming at the US$2 billion Chinese PPI injection market

 Last Update: 2021-07-29
 Source: Internet
 Author: User

Tags

high vacuum pump

plasminogen activator inhibitor

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

P-CAB, as a new type of acid-suppressing drug, makes up for the "pain points" of traditional acid-suppressing drugs PPI, which requires acid activation, short half-life and insufficient acid suppression, resulting in low mucosal healing rate

Tigolasan injection is mainly used for the treatment of gastroesophageal reflux, upper gastrointestinal bleeding and prevention of stress gastric mucosal injury, etc.

According to IQVIA data, China's proton pump inhibitor (PPI) drug market in 2020 will be approximately US$3 billion, ranking second in the world after the United States, of which the injection market size is approximately US$2 billion and approximately RMB 12.

The cooperation between Luoxin Pharmaceutical and HK inno.

According to IQVIA data, the global sales of ticolax tablets in 2020 will be US$50 million (calculated at the ex-factory price), an increase of 106% year-on-year

In June 2017, Luoxin's LXI-15028 project obtained clinical trial approval.

The cooperation between China and South Korea on tegoraxan injection products further demonstrates Luoxin Pharmaceutical's R&D and commercialization advantages in the gastrointestinal field

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.